NeuMind Clinic - Arlington Heights
3205 North Wilke Road, Unit 106, Arlington Heights
5.0(63 Google reviews)
United States
No clinic sits inside Palatine itself. The closest verified clinic is 2.3 miles away, in Arlington Heights.
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Palatine.
2.3 miles away · Arlington Heights
3205 North Wilke Road, Unit 106, Arlington Heights
5.0(63 Google reviews)
3.5 miles away · Deer Park
4.7 miles away · Schaumburg
4.7 miles away · Schaumburg
1701 Woodfield Road, Suite 401, Schaumburg
4.4(174 Google reviews)
5.7 miles away · Schaumburg
1375 East Schaumburg Road, 240, Schaumburg
1.0(1 Google reviews)
8.8 miles away · Des Plaines
For people in Palatine considering SPRAVATO®, costs depend on insurance benefits, the treatment setting, and the prescribed course of care. Ask for an estimate that separates the medication from the supervised treatment and monitoring visit: both may be billed, and your plan may handle those charges differently. An estimate is not a guarantee of final costs or coverage.
Prior authorization is common. Your insurer may require records of earlier antidepressant trials before deciding whether to approve treatment. Ask the center which records it needs, who will request them from previous prescribers, and who submits the authorization. Confirm whether approval covers both the medication and visits, how long it lasts, and whether ongoing treatment requires renewed authorization.
Medicare coverage may involve Part B or Part D, depending on the plan and setting. Illinois Medicaid coverage also depends on the plan and applicable requirements. Neither program guarantees coverage for every patient or location. Manufacturer savings programs exist for eligible commercially insured patients, but not for people using government insurance. Ask about current eligibility rules rather than assuming assistance will apply.
Before starting, ask the treatment center and insurer:
Also plan for transportation and time away from work. Those practical expenses matter even when treatment itself is covered.
There is currently no SPRAVATO® treatment center listed in Palatine in this directory. That means there is no local listing to review here—not necessarily that treatment is unavailable in the city. Other Illinois cities with listed centers include Chicago, Aurora, Naperville, and Orland Park. You can also explore listings in Rockford, Bloomington, Peoria, and Champaign. Compare locations based on your transportation options, appointment availability, and insurance, and confirm each center’s current REMS certification before scheduling.
Spravato is given only in a REMS-certified healthcare setting. You self-administer the nasal spray under a healthcare provider’s direct observation; it is never sent home with you. Monitoring lasts at least two hours after each dose, so allow more than two hours overall for check-in, treatment, and discharge assessment. Some visits may take longer.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines your schedule; do not assume a fixed long-term calendar.
Arrange for someone else to drive you home after every session. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its ride and discharge requirements before relying on a taxi or rideshare, and have a backup plan if your driver cancels.
When requesting time off work, account for travel, the full appointment, and recovery afterward. Discuss scheduling and any driving or machinery duties with your care team before committing to appointments.
This directory currently has no center listed in Palatine. You can explore listings in Chicago, Aurora, Naperville, or Orland Park, among other listed Illinois cities. A directory listing does not replace verification: contact the location to confirm current SPRAVATO® REMS certification, whether it accepts new patients, and whether it works with your insurance. Ask about evaluation requirements and transportation policies before scheduling.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved, with an oral antidepressant, for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. It is not approved for children. A clinician must review your symptoms, treatment history, and medical risks to determine whether it is appropriate; a diagnosis alone does not guarantee eligibility.
Coverage depends on your specific plan and the treatment setting, not simply the city where you live. Ask your insurer whether the location is in network and whether both the medication and monitoring visits are covered. Prior authorization and records of previous antidepressant trials are common requirements. Medicare and Illinois Medicaid may cover treatment depending on the plan and setting, but coverage must be checked individually.
You administer the nasal spray yourself under direct observation in a REMS-certified healthcare setting. The care team monitors you for at least two hours after the dose, including for sedation, dissociation, breathing problems, and blood pressure increases. Discharge depends on the team’s assessment, so a visit may run longer. You cannot take the medication home and must arrange for someone else to drive you home.
Important risks include sedation, dissociation—a feeling of disconnection from yourself or your surroundings—respiratory depression, and increased blood pressure. Boxed warnings also address abuse and misuse and suicidal thoughts and behaviors. Spravato is a Schedule III controlled substance. Discuss your medical history, medications, and substance use openly with the clinician. Monitoring helps the team assess your response, but it does not make treatment risk-free.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Do not wait for an evaluation or insurance approval if you need urgent help. Call or text 988 for crisis support, or call 911 if there is immediate danger. Tell your treatment team promptly about new or worsening suicidal thoughts.
Approved uses, nearby treatment centers, and medically sourced patient guides.